Levonorgestrel-based EC (Plan B)

The ACOG Committee Opinion’s support for over-the-counter hormonal contraception, efficacy of intracervical blocks for pain management during levonorgestrel IUD placement, studies on the mechanism of function of ulipristal acetate, and more.

Barriers to accessing EC pills exist, what are they and how can you help people get the EC pills they need.

The FDA has extended approval of LILETTA IUDs for up to 6 years of use, research shows they are safe and effective for up to 7 years.

The CDC’s yearly STD report, potential for a trivalent vaccine for genital herpes in the future, hormonal contraceptive use among women with opioid use disorder, improved patient bleeding patters with correct fundal placement of IUDs, and more.

An analysis of the efficacy and safety of telehealth medication abortion care, IUD use and a decreased risk of ovarian cancer, widespread support for HPV vaccination, and more.

Here’s what you and your patients should know about these two (very similar) hormonal IUDs.

Here’s what you need to know to help your patients balance risks and uncertainties related to starting hormonal birth control after ella.

Do you know what info your patients are getting about EC?